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We recently operated on a patient with an acute aortic dissec-
tion Stanford Type A. The postoperative period was uneventful.
Our intensive care unit team started anticoagulation for throm-
boprophylaxis within the ﬁrst postoperative day, basing their de-
cision on the European Association for Cardio-thoracic Surgery
(EACTS) guidelines [1]. After reviewing these and other guidelines
carefully, we realize that the EACTS guidelines give a general rec-
ommendation for all comers, advising that all patients who
undergo cardiac surgery receive prophylactic anticoagulation
from the ﬁrst postoperative day [1]. We ﬁnd that this recommen-
dation is too broad and merits discussion until updated guide-
lines are available.
There is a risk of deep vein thrombosis (DVT) and pulmonary
embolism (PE) following cardiac surgery. This complication is not
rare, but it not as high as in other types of surgery, such as
orthopedic surgery. The risk of DVT and/or PE after cardiac
surgery is deﬁned as moderate by the latest American College of
Chest Physicians guidelines [2].
The EACTS guidelines advise prophylactic anticoagulation for
all patients who have undergone cardiac surgery, which is not
correct, in our opinion. Every patient should be evaluated on
his/her own basis according to personal risk factors, operation
type, bleeding risk and platelet count, as mentioned in the
National Institute for Health and Clinical Excellence (NICE)
recommendations [3].
We commend Dunning et al. for producing the EACTS
guidelines based on the available literature; however, the
studies they are based on are quite old. For example, the refer-
ences of the NICE recommendations are from 1980 to 1996
and include a limited number of patients; some of them do not
even include cardiac surgery patients. Among the ﬁve studies
used for the NICE recommendations on thromboprophylaxis fol-
lowing cardiac surgery, two include only vascular surgery
patients, and the study populations are very small. Interestingly,
one study shows eight times more bleeding with prophylactic
anticoagulation, although this is not mentioned as the P-value
was >0.05.
Cardiac surgery patients are a different population from
general or orthopedic surgery patients who represent the major-
ity of patients included in the studies that were used as the basis
of the EACTS guidelines. How many general surgery patients
have 2 h of foreign surface-blood contact, haemostatic hurricane
and low platelet count with poor function? Finally, among the
studies that included cardiac surgery patients, the entire spec-
trum of cardiac surgery was not included. None of the studies
included enough aortic surgery patients, and most likely, no
aortic dissection patients. These are the subset of patients at
highest risk of bleeding and tamponade, yet should the recom-
mendations for prophylactic anticoagulation apply to them?
Clearly, there is a need to redraw the frame of thromboprophy-
laxis following cardiac surgery, including the indications and
timing, by organizing more studies including all subsets of patients.
Until these guidelines are prepared by our societies, all patients
should be discussed personally by calculating their risks of DVT,
bleeding, pericardial tamponade and beneﬁts of preventing PE.
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